Omnicell (OMCL) Cash & Equivalents Growth (3y) (2013 - 2026)
Powered by 
Analysis
Omnicell (OMCL) Cash & Equivalents Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | -13.31% |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | -7.03% |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 8.09% |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 34.27% |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 8.16% |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 40.74% |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 27.03% |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | -2.57% |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 86.12% |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | -9.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.90% |
| Mar 31, 2026 | -11.09% |
| Dec 31, 2025 | -15.90% |
| Sep 30, 2025 | -12.23% |
| Jun 30, 2025 | 17.66% |
| Mar 31, 2025 | 13.44% |
| Dec 31, 2024 | 1.89% |
| Sep 30, 2024 | 5.82% |
| Jun 30, 2024 | -3.22% |
| Mar 31, 2024 | -2.22% |
| Dec 31, 2023 | -1.25% |
| Sep 30, 2023 | -10.78% |
| Jun 30, 2023 | 44.07% |
| Mar 31, 2023 | 48.44% |
| Dec 31, 2022 | 37.45% |
| Sep 30, 2022 | 24.73% |
| Jun 30, 2022 | 40.94% |
| Mar 31, 2022 | 50.82% |
| Dec 31, 2021 | 73.19% |
| Sep 30, 2021 | 121.73% |